治疗策略在老年患者与可手术,激素受体阴性乳腺癌的治疗策略
Tatsuhiko Ikeda1, Misuzu Takeda1, Munechika Tsuji1
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan.
Cancer diagnosis & prognosis
|January 6, 2025
概括
75岁以上的患有荷尔蒙受体阴性乳腺癌的老年患者可能不会从手术,放射或化疗中受益. 对老年人的治疗决定需要仔细考虑与年龄相关的因素.
科学领域:
- 在瘤学瘤学.
- 老年医学 老年医学
- 临床试验 临床试验
背景情况:
- 老年患者,特别是那些患有荷尔蒙受体阴性乳腺癌的患者,在临床试验中代表性不足.
- 这可能导致该人口群体的治疗策略不足.
研究的目的:
- 根据年龄组,比较激素受体阴性乳腺癌的老年患者的治疗模式和结果.
- 调查在最年长的老年人群中省略某些治疗的影响.
主要方法:
- 对126名经过手术治疗的荷尔蒙受体阴性乳腺癌患者的回顾性审查.
- 75岁以上的患者 (A组) 与65-74岁的患者 (B组) 的比较.
主要成果:
- 与B组 (65-74岁) 相比,A组 (≥75岁) 的遗漏下手术 (15%对2%),放射治疗 (13%对44%) 和化疗 (79%对23%) 的比率显著更高.
- 两组之间没有观察到乳腺癌特定存活率或整体存活率的显著差异.
结论:
- 缺失手术,放射治疗或化疗可能不会对75岁以上的荷尔蒙受体阴性乳腺癌患者的预后产生负面影响.
- 与年龄相关的因素在标准化乳腺癌老年患者最佳治疗决策方面存在挑战.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Combination Therapies and Personalized Medicine
4.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.7K


